beta

AEMD

Aethlon Medical Inc.

Aemd

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-06-2018 after market close 08-08-2018 after market close 06-08-2018 after market close 02-01-2018 after market close 11-02-2017 after market close 08-10-2017 after market close 06-28-2017 after market close 02-10-2017 after market close 11-10-2016 after market close 08-11-2016 after market close
Actual EPS -0.08 -0.06 -0.06 -0.08 -0.14 -0.21 -0.22 -0.15 -0.29 -0.28
Consensus EPS -0.07 -0.08 -0.1 -0.12 -0.16 -0.16 -0.18 -0.16 -0.15 -0.2
Estimated EPS -0.07 -0.08 -0.1 -0.12 -0.16 -0.16 -0.18 -0.16 -0.15 -0.2
Number of Estimates 2 2 2 2 1 1 1 1 1 1
EPS Surprise -$0.01 $0.02 $0.04 $0.04 $0.02 -$0.05 -$0.04 $0.01 -$0.14 -$0.08

Stats

Summary

Aethlon Medical Inc is a medical device company focused on creating devices that address the unmet medical needs in cancer, infectious disease and other life-threatening conditions.

Market Cap: 22.5 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.aethlonmedical.com

Shares Outstanding: 15.1 Million

Float: 12.2 Million

Dividend: 0.0 (0.0%)

Beta: 2.289758

Sector: Technology

Industry: Computer Hardware

Short Interest (Jan 12, 2018): 1.31 Million

Ethical Flags

Longest drawdown: 1012 trading days

From: 2014-11-24 To: 2018-12-11

Lowest Point:

Technology movers and shakers

via: SeekingAlpha at 2018-11-29 15:02:43:000

More news on: Marin Software, iCAD, Inc., RF Industries, Ltd., Tech stocks news, Stocks on the move, , Read more … read more...

Technology movers and shakers

via: SeekingAlpha at 2018-11-29 15:02:43:000

More news on: Marin Software, iCAD, Inc., RF Industries, Ltd., Tech stocks news, Stocks on the move, , Read more … read more...

Technology movers and shakers

via: SeekingAlpha at 2018-11-29 15:02:43:000

More news on: Marin Software, iCAD, Inc., RF Industries, Ltd., Tech stocks news, Stocks on the move, , Read more … read more...

Technology - Top 5 Gainers / Losers as of 3.00 PM

via: SeekingAlpha at 2018-11-27 15:00:38:000

More news on: Aethlon Medical, Inc., DAQO New Energy Corp., Sphere 3D Corp., Tech stocks news, Stocks on the move, Read more … read more...

Technology - Top 5 Gainers / Losers as of 3.00 PM

via: SeekingAlpha at 2018-11-27 15:00:38:000

More news on: Aethlon Medical, Inc., DAQO New Energy Corp., Sphere 3D Corp., Tech stocks news, Stocks on the move, Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

Healthcare & Tech dominate midday movers

via: SeekingAlpha at 2018-11-27 12:44:38:000

More news on: Arsanis, Inc., Sphere 3D Corp., Aethlon Medical, Inc., Stocks on the move, , Read more … read more...

FRO, SAVE among premarket gainers

via: SeekingAlpha at 2018-11-27 09:10:58:000

Aethlon Medical (NASDAQ: AEMD ) +37% on accelerated review status for Hemopurifier in cancer. More news on: Aethlon Medical, Inc., Arsanis, Inc., Spirit Airlines, Stocks on the move, , Read more … read more...

FRO, SAVE among premarket gainers

via: SeekingAlpha at 2018-11-27 09:10:58:000

Aethlon Medical (NASDAQ: AEMD ) +37% on accelerated review status for Hemopurifier in cancer. More news on: Aethlon Medical, Inc., Arsanis, Inc., Spirit Airlines, Stocks on the move, , Read more … read more...

Aethlon Medical up 75% premarket on accelerated review status for Hemopurifier in cancer

via: SeekingAlpha at 2018-11-27 08:13:33:000

Thinly traded nano cap Aethlon Medical (NASDAQ: AEMD ) is up 75% premarket on increased volume in apparent response to the FDA designating the Hemopurifier a Breakthrough Device for the treatment of cancer, the second such designation for the product. More news on: Aethlon Me… read more...

Aethlon Medical up 75% premarket on accelerated review status for Hemopurifier in cancer

via: SeekingAlpha at 2018-11-27 08:13:33:000

Thinly traded nano cap Aethlon Medical (NASDAQ: AEMD ) is up 75% premarket on increased volume in apparent response to the FDA designating the Hemopurifier a Breakthrough Device for the treatment of cancer, the second such designation for the product. More news on: Aethlon Me… read more...

Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration

via: PR Newswire at 2018-11-27 07:21:00:000

SAN DIEGO , Nov. 27, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, announced today that it has received a "Breakthrough Device" designation from the U.S. Food and Drug Administration (FDA) to support th… read more...

Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration

via: PR Newswire at 2018-11-27 07:21:00:000

SAN DIEGO , Nov. 27, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, announced today that it has received a "Breakthrough Device" designation from the U.S. Food and Drug Administration (FDA) to support th… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q2 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-06 21:08:03:000

Aethlon Medical, Inc. (AEMD) Q2 2019 Earnings Conference Call November 06, 2018, 16:30 ET Executives Jim Joyce - CEO Jim Frakes - CFO Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Presentation Operator Good day, and welcome to the Aet… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q2 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-06 21:08:03:000

Aethlon Medical, Inc. (AEMD) Q2 2019 Earnings Conference Call November 06, 2018, 16:30 ET Executives Jim Joyce - CEO Jim Frakes - CFO Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Presentation Operator Good day, and welcome to the Aet… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q2 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-06 21:08:03:000

Aethlon Medical, Inc. (AEMD) Q2 2019 Earnings Conference Call November 06, 2018, 16:30 ET Executives Jim Joyce - CEO Jim Frakes - CFO Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Presentation Operator Good day, and welcome to the Aet… read more...

Aethlon Medical reports Q2 results

via: SeekingAlpha at 2018-11-06 16:53:05:000

Aethlon Medical (NASDAQ: AEMD ): Q2 GAAP EPS of -$0.08. More news on: Aethlon Medical, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results

via: PR Newswire at 2018-11-06 16:15:00:000

SAN DIEGO , Nov. 6, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today announced results for its fiscal second quarter ended September 30, 2018 . Second Quarter Financial Results The Compan… read more...

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

via: PR Newswire at 2018-11-01 08:30:00:000

SAN DIEGO , Nov. 1, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health today announced it will issue financial results for the second quarter fiscal year 2019 ended September 30, 2018 at 4:15pm eastern tim… read more...

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

via: PR Newswire at 2018-11-01 08:30:00:000

SAN DIEGO , Nov. 1, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health today announced it will issue financial results for the second quarter fiscal year 2019 ended September 30, 2018 at 4:15pm eastern tim… read more...

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

via: PR Newswire at 2018-11-01 08:30:00:000

SAN DIEGO , Nov. 1, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health today announced it will issue financial results for the second quarter fiscal year 2019 ended September 30, 2018 at 4:15pm eastern tim… read more...

Aethlon Medical (AEMD) Presents At NYC Oncology Investor Conference - Slideshow

via: SeekingAlpha at 2018-10-31 12:43:36:000

The following slide deck was published by Aethlon Medical, Inc. in conjunction with this Read more … read more...

Aethlon Medical to Present at the NYC Oncology Conference

via: PR Newswire at 2018-10-29 11:59:00:000

SAN DIEGO , Oct. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), an immunotherapeutic technology company focused on unmet needs in global health, today announced that its CEO, Jim Joyce , will present at the NYC Oncology Investor Conference on Tuesday, October 30, 2018 at… read more...

Aethlon Medical to Present at the NYC Oncology Conference

via: PR Newswire at 2018-10-29 11:59:00:000

SAN DIEGO , Oct. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), an immunotherapeutic technology company focused on unmet needs in global health, today announced that its CEO, Jim Joyce , will present at the NYC Oncology Investor Conference on Tuesday, October 30, 2018 at… read more...

Aethlon Medical to Present at the 2018 BIO Investor Forum

via: PR Newswire at 2018-10-16 08:15:00:000

SAN DIEGO , Oct. 16, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq:AEMD), an immunotherapeutic technology company focused on unmet needs in global health, today announced that its CEO, Jim Joyce , will present at the 2018 BIO Investor Forum on Thursday, October 18, 2018 at 3… read more...

Aethlon Medical to Present at the 2018 BIO Investor Forum

via: PR Newswire at 2018-10-16 08:15:00:000

SAN DIEGO , Oct. 16, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq:AEMD), an immunotherapeutic technology company focused on unmet needs in global health, today announced that its CEO, Jim Joyce , will present at the 2018 BIO Investor Forum on Thursday, October 18, 2018 at 3… read more...

Aethlon Medical to Present at the 2018 BIO Investor Forum

via: PR Newswire at 2018-10-16 08:15:00:000

SAN DIEGO , Oct. 16, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq:AEMD), an immunotherapeutic technology company focused on unmet needs in global health, today announced that its CEO, Jim Joyce , will present at the 2018 BIO Investor Forum on Thursday, October 18, 2018 at 3… read more...

Aethlon Medical Receives National Cancer Institute Award

via: PR Newswire at 2018-09-18 08:46:00:000

SAN DIEGO , Sept. 18, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the National Cancer Institute (NCI) has awarded the Company a government grant (number 1R43CA… read more...

Aethlon Medical Receives National Cancer Institute Award

via: PR Newswire at 2018-09-18 08:46:00:000

SAN DIEGO , Sept. 18, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the National Cancer Institute (NCI) has awarded the Company a government grant (number 1R43CA… read more...

Aethlon Medical Receives National Cancer Institute Award

via: PR Newswire at 2018-09-18 08:46:00:000

SAN DIEGO , Sept. 18, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the National Cancer Institute (NCI) has awarded the Company a government grant (number 1R43CA… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-09 02:20:59:000

Aethlon Medical, Inc. (AEMD) Q1 2019 Earnings Conference Call August 8, 2018 16:30 ET Executives Jim Frakes - CFO Jim Joyce - CEO Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Marc Robins - Catalyst Research Presentation Operator Go… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-09 02:20:59:000

Aethlon Medical, Inc. (AEMD) Q1 2019 Earnings Conference Call August 8, 2018 16:30 ET Executives Jim Frakes - CFO Jim Joyce - CEO Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Marc Robins - Catalyst Research Presentation Operator Go… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-09 02:20:59:000

Aethlon Medical, Inc. (AEMD) Q1 2019 Earnings Conference Call August 8, 2018 16:30 ET Executives Jim Frakes - CFO Jim Joyce - CEO Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Marc Robins - Catalyst Research Presentation Operator Go… read more...

Aethlon Medical beats by $0.02

via: SeekingAlpha at 2018-08-08 16:33:03:000

Aethlon Medical (NASDAQ: AEMD ): Q1 EPS of -$0.06 beats by $0.02 . More news on: Aethlon Medical, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aethlon Medical Announces First Quarter Fiscal Year 2019 Results

via: PR Newswire at 2018-08-08 16:15:00:000

SAN DIEGO , Aug. 8, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal first quarter ended June 30, 2018 . First Quarter Financial Results At… read more...

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

via: PR Newswire at 2018-08-02 08:15:00:000

SAN DIEGO , Aug. 2, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue financial results for the first quarter fiscal year 2019 ended June 30, 2018 at 4:1… read more...

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

via: PR Newswire at 2018-08-02 08:15:00:000

SAN DIEGO , Aug. 2, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue financial results for the first quarter fiscal year 2019 ended June 30, 2018 at 4:1… read more...

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

via: PR Newswire at 2018-08-02 08:15:00:000

SAN DIEGO , Aug. 2, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue financial results for the first quarter fiscal year 2019 ended June 30, 2018 at 4:1… read more...

Aethlon Medical issues Hemopurifier patent to treat life-threatening viruses, shares up 3% premarket

via: SeekingAlpha at 2018-07-23 09:13:05:000

Aethlon Medical (NASDAQ: AEMD ) announces the issuance of U.S. Patent No. 10,022,483. More news on: Aethlon Medical, Inc., Healthcare stocks news, Read more … read more...

Aethlon Medical issues Hemopurifier patent to treat life-threatening viruses, shares up 3% premarket

via: SeekingAlpha at 2018-07-23 09:13:05:000

Aethlon Medical (NASDAQ: AEMD ) announces the issuance of U.S. Patent No. 10,022,483. More news on: Aethlon Medical, Inc., Healthcare stocks news, Read more … read more...

Aethlon Medical issues Hemopurifier patent to treat life-threatening viruses, shares up 3% premarket

via: SeekingAlpha at 2018-07-23 09:13:05:000

Aethlon Medical (NASDAQ: AEMD ) announces the issuance of U.S. Patent No. 10,022,483. More news on: Aethlon Medical, Inc., Healthcare stocks news, Read more … read more...

Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses

via: PR Newswire at 2018-07-23 08:15:00:000

SAN DIEGO , July 23, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the issuance of U.S. Patent No. 10,022,483 ("the '483Patent"). The '483 Patent protects… read more...

Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses

via: PR Newswire at 2018-07-23 08:15:00:000

SAN DIEGO , July 23, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the issuance of U.S. Patent No. 10,022,483 ("the '483Patent"). The '483 Patent protects… read more...

Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses

via: PR Newswire at 2018-07-23 08:15:00:000

SAN DIEGO , July 23, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the issuance of U.S. Patent No. 10,022,483 ("the '483Patent"). The '483 Patent protects… read more...

Guy Cipriani Joins Aethlon Medical's Board of Directors

via: PR Newswire at 2018-06-25 09:15:00:000

SAN DIEGO , June 25, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Guy Cipriani to its Board of Directors. Mr. Cipriani qualifies as an independe… read more...

Guy Cipriani Joins Aethlon Medical's Board of Directors

via: PR Newswire at 2018-06-25 09:15:00:000

SAN DIEGO , June 25, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Guy Cipriani to its Board of Directors. Mr. Cipriani qualifies as an independe… read more...

Guy Cipriani Joins Aethlon Medical's Board of Directors

via: PR Newswire at 2018-06-25 09:15:00:000

SAN DIEGO , June 25, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Guy Cipriani to its Board of Directors. Mr. Cipriani qualifies as an independe… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-06-08 18:17:08:000

Aethlon Medical, Inc. (AEMD) Q4 2018 Earnings Conference Call June 08, 2018 04:30 PM ET Executives Jim Frakes - Chief Financial Officer Jim Joyce - Chief Executive Officer Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Presentation Operat… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-06-08 18:17:08:000

Aethlon Medical, Inc. (AEMD) Q4 2018 Earnings Conference Call June 08, 2018 04:30 PM ET Executives Jim Frakes - Chief Financial Officer Jim Joyce - Chief Executive Officer Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Presentation Operat… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-06-08 18:17:08:000

Aethlon Medical, Inc. (AEMD) Q4 2018 Earnings Conference Call June 08, 2018 04:30 PM ET Executives Jim Frakes - Chief Financial Officer Jim Joyce - Chief Executive Officer Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Presentation Operat… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-06-08 18:17:08:000

Aethlon Medical, Inc. (AEMD) Q4 2018 Earnings Conference Call June 08, 2018 04:30 PM ET Executives Jim Frakes - Chief Financial Officer Jim Joyce - Chief Executive Officer Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Presentation Operat… read more...

Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-06-08 18:17:08:000

Aethlon Medical, Inc. (AEMD) Q4 2018 Earnings Conference Call June 08, 2018 04:30 PM ET Executives Jim Frakes - Chief Financial Officer Jim Joyce - Chief Executive Officer Analysts Brian Marckx - Zacks Investment Research Yi Chen - H.C. Wainwright Presentation Operat… read more...

Aethlon Medical beats by $0.02

via: SeekingAlpha at 2018-06-08 16:18:41:000

Aethlon Medical (NASDAQ: AEMD ): FY EPS of -$0.46 beats by $0.02 . More news on: Aethlon Medical, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...

Aethlon Medical beats by $0.02

via: SeekingAlpha at 2018-06-08 16:18:41:000

Aethlon Medical (NASDAQ: AEMD ): FY EPS of -$0.46 beats by $0.02 . More news on: Aethlon Medical, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...

Aethlon Medical beats by $0.02

via: SeekingAlpha at 2018-06-08 16:18:41:000

Aethlon Medical (NASDAQ: AEMD ): FY EPS of -$0.46 beats by $0.02 . More news on: Aethlon Medical, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...

Aethlon Medical beats by $0.02

via: SeekingAlpha at 2018-06-08 16:18:41:000

Aethlon Medical (NASDAQ: AEMD ): FY EPS of -$0.46 beats by $0.02 . More news on: Aethlon Medical, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...

Aethlon Medical beats by $0.02

via: SeekingAlpha at 2018-06-08 16:18:41:000

Aethlon Medical (NASDAQ: AEMD ): FY EPS of -$0.46 beats by $0.02 . More news on: Aethlon Medical, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...

Aethlon Medical Announces Fiscal 2018 Results

via: PR Newswire at 2018-06-08 16:15:00:000

SAN DIEGO , June 8, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal year ended March 31, 2018 . Recent Corporate Developments During the fiscal… read more...

Aethlon Medical Announces Fiscal 2018 Results

via: PR Newswire at 2018-06-08 16:15:00:000

SAN DIEGO , June 8, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal year ended March 31, 2018 . Recent Corporate Developments During the fiscal… read more...

Aethlon Medical Announces Fiscal 2018 Results

via: PR Newswire at 2018-06-08 16:15:00:000

SAN DIEGO , June 8, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal year ended March 31, 2018 . Recent Corporate Developments During the fiscal… read more...

Aethlon Medical Announces Fiscal 2018 Results

via: PR Newswire at 2018-06-08 16:15:00:000

SAN DIEGO , June 8, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal year ended March 31, 2018 . Recent Corporate Developments During the fiscal… read more...

Aethlon Medical Announces Fiscal 2018 Results

via: PR Newswire at 2018-06-08 16:15:00:000

SAN DIEGO , June 8, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal year ended March 31, 2018 . Recent Corporate Developments During the fiscal… read more...

Aethlon Medical (AEMD) Presents At BIO International Convention - Slideshow

via: SeekingAlpha at 2018-06-07 13:38:03:000

The following slide deck was published by Aethlon Medical, Inc. in conjunction with this Read more … read more...

Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018

via: PR Newswire at 2018-05-31 08:45:00:000

SAN DIEGO , May 31, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue financial results for the fiscal year ended March 31, 2018 at 4:15pm Eastern Time on Frid… read more...

Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018

via: PR Newswire at 2018-05-31 08:45:00:000

SAN DIEGO , May 31, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue financial results for the fiscal year ended March 31, 2018 at 4:15pm Eastern Time on Frid… read more...

Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018

via: PR Newswire at 2018-05-31 08:45:00:000

SAN DIEGO , May 31, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue financial results for the fiscal year ended March 31, 2018 at 4:15pm Eastern Time on Frid… read more...

Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix

via: PR Newswire at 2018-03-22 08:00:00:000

PHOENIX and SAN DIEGO , March 22, 2018 /PRNewswire/ --Exosome Sciences, Inc., a diagnostic subsidiary of Aethlon Medical, Inc. (Nasdaq: AEMD), today announced the initiation of an Institutional Review Board (IRB) approved protocol for a research study involving retired NFL players… read more...

Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix

via: PR Newswire at 2018-03-22 08:00:00:000

PHOENIX and SAN DIEGO , March 22, 2018 /PRNewswire/ --Exosome Sciences, Inc., a diagnostic subsidiary of Aethlon Medical, Inc. (Nasdaq: AEMD), today announced the initiation of an Institutional Review Board (IRB) approved protocol for a research study involving retired NFL players… read more...

Midday Gainers / Losers (03/21/2018)

via: SeekingAlpha at 2018-03-21 12:45:41:000

CALI +48% . MARA +26% . DXPE +20% . KMPH +16% . GERN +15% . TGEN +15% . NH +15% . ARNA +13% . PRTA +13% . TCCO +12% . More news on: China Auto Logistics Inc., Marathon Patent Group, Inc., DXP Enterprises, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (03/21/2018)

via: SeekingAlpha at 2018-03-21 12:45:41:000

CALI +48% . MARA +26% . DXPE +20% . KMPH +16% . GERN +15% . TGEN +15% . NH +15% . ARNA +13% . PRTA +13% . TCCO +12% . More news on: China Auto Logistics Inc., Marathon Patent Group, Inc., DXP Enterprises, Inc., Stocks on the move, , Read more … read more...

Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting

via: PR Newswire at 2018-02-12 06:32:00:000

SAN DIEGO , Feb. 12, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that its CEO, Jim Joyce will give a presentation at the 2018 American Society for Microbiology (A… read more...

Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting

via: PR Newswire at 2018-02-12 06:32:00:000

SAN DIEGO , Feb. 12, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that its CEO, Jim Joyce will give a presentation at the 2018 American Society for Microbiology (A… read more...

Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting

via: PR Newswire at 2018-02-12 06:32:00:000

SAN DIEGO , Feb. 12, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that its CEO, Jim Joyce will give a presentation at the 2018 American Society for Microbiology (A… read more...

Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting

via: PR Newswire at 2018-02-12 06:32:00:000

SAN DIEGO , Feb. 12, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that its CEO, Jim Joyce will give a presentation at the 2018 American Society for Microbiology (A… read more...

Aethlon Medical's (AEMD) CEO Jim Joyce on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-01 21:05:06:000

Aethlon Medical, Inc. (AEMD) Q3 2018 Earnings Conference Call February 1, 2018 4:30 PM ET Executives John Marco Managing Director-Core IR Jim Joyce Chief Executive Officer Jim Frakes Chief Financial Officer Analysts Brian Marckx Zacks Inv… read more...

Aethlon Medical's (AEMD) CEO Jim Joyce on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-01 21:05:06:000

Aethlon Medical, Inc. (AEMD) Q3 2018 Earnings Conference Call February 1, 2018 4:30 PM ET Executives John Marco Managing Director-Core IR Jim Joyce Chief Executive Officer Jim Frakes Chief Financial Officer Analysts Brian Marckx Zacks Inv… read more...

Aethlon Medical's (AEMD) CEO Jim Joyce on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-01 21:05:06:000

Aethlon Medical, Inc. (AEMD) Q3 2018 Earnings Conference Call February 1, 2018 4:30 PM ET Executives John Marco Managing Director-Core IR Jim Joyce Chief Executive Officer Jim Frakes Chief Financial Officer Analysts Brian Marckx Zacks Inv… read more...

Aethlon Medical's (AEMD) CEO Jim Joyce on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-01 21:05:06:000

Aethlon Medical, Inc. (AEMD) Q3 2018 Earnings Conference Call February 1, 2018 4:30 PM ET Executives John Marco Managing Director-Core IR Jim Joyce Chief Executive Officer Jim Frakes Chief Financial Officer Analysts Brian Marckx Zacks Inv… read more...

Aethlon Medical's (AEMD) CEO Jim Joyce on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-01 21:05:06:000

Aethlon Medical, Inc. (AEMD) Q3 2018 Earnings Conference Call February 1, 2018 4:30 PM ET Executives John Marco Managing Director-Core IR Jim Joyce Chief Executive Officer Jim Frakes Chief Financial Officer Analysts Brian Marckx Zacks Inv… read more...

Aethlon Medical reports Q3 results

via: SeekingAlpha at 2018-02-01 16:20:51:000

Aethlon Medical (NASDAQ: AEMD ): Q3 EPS of -$0.08 Revenue of $0.08M Press Release More news on: Aethlon Medical, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Aethlon Medical reports Q3 results

via: SeekingAlpha at 2018-02-01 16:20:51:000

Aethlon Medical (NASDAQ: AEMD ): Q3 EPS of -$0.08 Revenue of $0.08M Press Release More news on: Aethlon Medical, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Aethlon Medical reports Q3 results

via: SeekingAlpha at 2018-02-01 16:20:51:000

Aethlon Medical (NASDAQ: AEMD ): Q3 EPS of -$0.08 Revenue of $0.08M Press Release More news on: Aethlon Medical, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Aethlon Medical reports Q3 results

via: SeekingAlpha at 2018-02-01 16:20:51:000

Aethlon Medical (NASDAQ: AEMD ): Q3 EPS of -$0.08 Revenue of $0.08M Press Release More news on: Aethlon Medical, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Aethlon Medical Announces Fiscal 2018 Third Quarter Results

via: PR Newswire at 2018-02-01 16:15:00:000

SAN DIEGO , Feb. 1, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal third quarter ended December 31, 2017 . Recent Corporate Developments … read more...

Aethlon Medical Announces Fiscal 2018 Third Quarter Results

via: PR Newswire at 2018-02-01 16:15:00:000

SAN DIEGO , Feb. 1, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal third quarter ended December 31, 2017 . Recent Corporate Developments … read more...

Aethlon Medical Announces Fiscal 2018 Third Quarter Results

via: PR Newswire at 2018-02-01 16:15:00:000

SAN DIEGO , Feb. 1, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal third quarter ended December 31, 2017 . Recent Corporate Developments … read more...

Aethlon Medical Announces Fiscal 2018 Third Quarter Results

via: PR Newswire at 2018-02-01 16:15:00:000

SAN DIEGO , Feb. 1, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal third quarter ended December 31, 2017 . Recent Corporate Developments … read more...

Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018

via: PR Newswire at 2018-01-29 08:15:00:000

SAN DIEGO , Jan. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue third quarter results for the fiscal year ended March 31, 2018 at 4:15 pm eastern time o… read more...

Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018

via: PR Newswire at 2018-01-29 08:15:00:000

SAN DIEGO , Jan. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue third quarter results for the fiscal year ended March 31, 2018 at 4:15 pm eastern time o… read more...

Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018

via: PR Newswire at 2018-01-29 08:15:00:000

SAN DIEGO , Jan. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue third quarter results for the fiscal year ended March 31, 2018 at 4:15 pm eastern time o… read more...

Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018

via: PR Newswire at 2018-01-29 08:15:00:000

SAN DIEGO , Jan. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue third quarter results for the fiscal year ended March 31, 2018 at 4:15 pm eastern time o… read more...

Premarket Gainers as of 9:05 am (1/23/2018)

via: SeekingAlpha at 2018-01-23 09:24:18:000

RGSE +39% . More news on: RGS Energy, Inc., ChinaNet Online Holdings, Inc., Aethlon Medical, Inc., Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am (1/23/2018)

via: SeekingAlpha at 2018-01-23 09:24:18:000

RGSE +39% . More news on: RGS Energy, Inc., ChinaNet Online Holdings, Inc., Aethlon Medical, Inc., Stocks on the move, Read more … read more...

Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes

via: PR Newswire at 2018-01-23 08:15:00:000

SAN DIEGO , Jan. 23, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that validation has completed and the opposition period expired for European Patent Number 2591359, enti… read more...

Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes

via: PR Newswire at 2018-01-23 08:15:00:000

SAN DIEGO , Jan. 23, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that validation has completed and the opposition period expired for European Patent Number 2591359, enti… read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-18 09:22:31:000

LIVE +28% on FY result . More news on: Live Ventures, Marathon Patent Group, Inc., Five Oaks Investment, Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-18 09:22:31:000

LIVE +28% on FY result . More news on: Live Ventures, Marathon Patent Group, Inc., Five Oaks Investment, Stocks on the move, Read more … read more...

Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections

via: PR Newswire at 2018-01-18 07:49:00:000

SAN DIEGO , Jan. 18, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application Number 14/490,418… read more...

Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors

via: PR Newswire at 2018-01-10 09:01:00:000

SAN DIEGO , Jan. 10, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Sabrina Martucci Johnson to its Board of Directors and to its Audit Committee…. read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-01-08 12:59:55:000

Gainers: MYSZ +70% . DELT +29% . APHB +22% . GALT +18% . SIFY +17% . AMSC +17% . LPCN +17% . VUZI +17% . NVRO +16% . CBMG +16% . More news on: MySize Inc., Delta Technology Holdings Limited, Ampliphi Biosciences Corp., Stocks on the move, Read more … ... read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-01-04 12:40:33:000

Gainers: CNET +315% . APOP +48% . HTGM +42% . AEMD +42% . CCXI +34% . OMF +24% . CMCM +20% . CCCR +18% . TCCO +17% . APHB +17% . More news on: ChinaNet Online Holdings, Inc., Cellect Biotechnology Ltd., HTG Molecular Diagnostics, Stocks on the move, Rea… read more...

Aethlon Medical up 33% ahead of 60 Minutes report of CTE in combat veterans

via: SeekingAlpha at 2018-01-04 12:05:13:000

Nano cap Aethlon Medical ( AEMD +33.3% ) spikes on modestly higher volume in apparent response to an upcoming segment of 60 Minutes (Sunday, Jan. 7) about the same degenerative brain disease in soldiers returning from combat as former football players. More news on: Aethlon Medical, In… read more...

Premarket Losers as of 9:05 am

via: SeekingAlpha at 2017-12-14 09:12:49:000

PIR -27% on Q2 earnings . More news on: Pier 1 Imports Inc., Criteo S.A., Sibanye-Stillwater, Stocks on the move, Read more … read more...

Aethlon Medical breaks out, shares up 38%

via: SeekingAlpha at 2017-12-13 15:25:02:000

Nano cap Aethlon Medical ( AEMD +37.5% ) breaks out of a two-month base on more than a 6x surge in volume. No particular news account for the action. Many times it presages an equity offering although the company just completed one two months ago. More news on: Aethlon Medical, Inc., Hea… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-04-14 50.0 1.0 50.0
Data provided for free by IEX